#United States #New Jersey #Class Action #Pomerantz Law #Nano-X

Pomerantz Law Firm Files Class Action Against Nano-X Imaging Ltd.

Pomerantz LLP, a prominent law firm based in New York, has announced the initiation of a class action lawsuit against Nano-X Imaging Ltd., a company traded on the NASDAQ under the ticker symbol NNOX. This lawsuit targets both the company and specific officers, reflecting serious allegations concerning the violation of federal securities laws.

Filed in the United States District Court for the District of New Jersey, the lawsuit aims to represent all individuals and entities who purchased or acquired shares of Nano-X securities between March 31, 2025, and April 17, 2026. The allegations suggest a range of misconduct that has potentially harmed investors.

Context of the Lawsuit

Nano-X Imaging specializes in developing commercial-grade imaging technology, including a digital X-ray source and associated teleradiology services. The company claimed significant advancements in its manufacturing processes, suggesting that these improvements would lead to increased profitability and reduced operational costs. However, the complaint argues that these claims were bolstered by misleading statements that concealed the reality of the company’s financial health and operational effectiveness.

Details within the complaint assert that executives exaggerated the efficiency of Nano-X's operations and failed to disclose critical issues related to production and financial management. Alignment between manufacturing capabilities and product demand was stated to be mismanaged, leading to unanticipated operating expenses and cash shortages.

Emergence of Truth

On April 20, 2026, the truth about Nano-X's financial standing began to emerge. The company released its fourth quarter 2025 financial results, revealing a net loss of $33.4 million, which included a significant charge due to impairments from a restructuring strategy at its Korean manufacturing facility. This press release notably marked the resignation of the company's Chief Financial Officer, raising further concerns about the leadership's direction.

In their earnings call on the same day, CEO Erez Meltzer confirmed the need for operational adjustments, stating that the company required a transition to a more efficient outsourcing model that aligned better with demand forecasts. This disclosure severely impacted Nano-X’s stock price, which plummeted by over 24% in a single trading session following the announcement.

Investor Action

Investors who acquired Nano-X securities during this critical class period may qualify for participation in the class action. Those interested in pursuing claims or wishing to obtain more information about the legal proceedings are encouraged to reach out to Pomerantz LLP before the invested deadline of August 11, 2026.

About Pomerantz LLP

Founded by the late Abraham L. Pomerantz, a pioneer in class action litigation, Pomerantz LLP has built a reputable legacy in corporate and securities law, advocating for victims of fraud and corporate misconduct for over 85 years. Their commitment to championing the rights of affected investors has led to billions in damages recovered on behalf of class members.

For further inquiries and to discuss this action, investors can contact Danielle Peyton at Pomerantz via email or by phone. A complete version of the lodged complaint is accessible on Pomerantz's official website.

This legal action spotlights the critical importance of transparency and accountability in the corporate governance of publicly traded companies, as well as the ongoing vigilance required from investors to protect their interests in the financial markets.